Abstracts

LESSONS LEARNED FROM THE AMP TRIAL: IS THE GLASS HALF FULL?

The AMP (Antibody Mediated Prevention) trial was the first study to show that a broadly neutralizing antibody (bnAb), VRC01, could prevent HIV-1 acquisition. However, this protection was incomplete, with VRC01 only blocking highly sensitive viruses. Here we will explore innate and selected resistance in breakthrough infections from this trial. Using an updated virus panel, we…

SCOTT M. HAMMER WORKSHOP FOR NEW INVESTIGATORS AND TRAI

Over the past four decades, remarkable progress has been made in understanding HIV epidemiology, pathogenesis, treatment, and prevention from the combined efforts of community members, clinicians, investigators, and funding agencies worldwide. Yet more work and new approaches are needed to achieve the ambitious goal of ending the epidemic and ensuring optimal quality of life for…

THE HIV-1 PROVIRAL LANDSCAPE: WHAT HAVE WE LEARNED?

Genetic characterization of HIV-1 proviruses isolated from CD4+ T cells of individuals on effective antiretroviral therapy has revealed that only 2-12% of persistent HIV-1 is genetically-intact and potentially replication-competent. Replication-competent proviruses are the main barrier to HIV-1 eradication as they contribute to viral rebound if therapy is interrupted. Therefore, determining the source of latent replication-competent…

COVID-19 AND THE HIV CARE CONTINUUM IN C3PNO COHORTS

The COVID-19 pandemic disrupted the normal delivery of HIV care, altered social support networks, and caused economic insecurity. People with HIV (PWH) are vulnerable to such disruptions, particularly if they have a history of substance use. We describe engagement in care and adherence to antiretroviral therapy (ART) for PWH during the pandemic. From May 2020…

COVID-19 PANDEMIC IMPACT ON HIV PrEP PROGRAM ENGAGEMENT IN BRITISH COLUMBIA

In March 2020, British Columbia (BC) declared a COVID-19-related public health emergency. Measures to limit SARS-CoV-2 transmission impacted social behaviors and disrupted healthcare access. We examined client engagement in BC’s province-wide, publicly-funded HIV PrEP program before and during the COVID-19 pandemic. Using de-identified data from BC’s provincial PrEP Program, we describe client engagement in the…

IMPACT OF COVID OUTBREAK ON PREVENTION AND CARE FOR HIV AND STIs AT A LARGE HOSPITAL

Routine medical care was drastically affected by the overwhelming irruption of COVID-19 pandemic. We comprehensively assessed the impact of the COVID-19 pandemic on the prevention and care for HIV and other sexually transmitted infections at a large reference hospital providing preventive and clinical services for HIV infection and other sexually transmitted infections. We retrospectively compared…